Antipsychotics in Alzheimer's Tied to Increased Morbidity |
Journal Updates
eMediNexus Coverage from: 
Antipsychotics in Alzheimer's Tied to Increased Morbidity
eMediNexus,  11 October 2019
remove_red_eye 499 Views
#Internal Medicine #Neurology #Pharmacist #Psychiatry

0 Read Comments                

Alzheimers disease (AD) patients who receive antipsychotics have more morbidity, as indicated by a greater number of days spent in the hospital, compared with their counterparts who were not prescribed these agents, new research suggests.

During a 2-year period, AD patients taking antipsychotics had greater than 50% more accumulated hospital days than those not taking antipsychotics, with the strongest association observed during the first 6 months. The study was published online in the Journal of the American Medical Directors Organization.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now